11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat

Endocrinology. 1995 Apr;136(4):1809-12. doi: 10.1210/endo.136.4.7895695.

Abstract

The effects of 11 alpha- and 11 beta-hydroxyprogesterone (11 alpha-OHP, 11 beta-OHP), on the activity of the glucocorticoid inactivating enzyme 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) were studied. 11 alpha-OHP and 11 beta-OHP were potent inhibitors of both 11 beta-HSD1 in rat liver microsomes and 11 beta-HSD2 in lysates of JEG-3 cells, a human choriocarcinoma cell line. In addition, both progesterone metabolites were markedly potent in conferring mineralocorticoid activity upon B in the adrenalectomized rat. These results provide insight into the structural properties required of inhibitors of 11 beta-HSD activity and indicate a possible role for endogenous 11 beta-HSD inhibitors in the regulation of glucocorticoid-induced Na+ retention.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenases
  • Adrenalectomy*
  • Animals
  • Choriocarcinoma / enzymology
  • Corticosterone / pharmacology*
  • Humans
  • Hydroxyprogesterones / pharmacology*
  • Hydroxysteroid Dehydrogenases / antagonists & inhibitors*
  • Hydroxysteroid Dehydrogenases / metabolism
  • Male
  • Microsomes, Liver / enzymology
  • Natriuresis / drug effects
  • Potassium / urine
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Cells, Cultured

Substances

  • Hydroxyprogesterones
  • 11-hydroxyprogesterone
  • Hydroxysteroid Dehydrogenases
  • 11-beta-Hydroxysteroid Dehydrogenases
  • Potassium
  • Corticosterone